Be the first user to share a patient case with the community.
We look forward to receiving and sharing your anonymized patient cases to be discussed with an extended network of experts in the field of SRS & SBRT.
Watch the recorded presentations from five esteemed speakers that review the value of focal therapy for various disease proliferations, discuss the clinical impact of treatment efficiency for SRS and much more.
Manuel Todorovic, MSc, from the department of radiotherapy and radiation oncology at University Medical Center Hamburg-Eppendorf (UKE) discusses evaluating intra-fraction motion for cranial radiosurgery patients. He begins by giving a short introduction to Brainlab Elements Multiple Brain Mets SRS software. He then outlines the analysis thereof by presenting their study design as well as the analyzed data and results, including corrections in positioning and repositioning made with ExacTrac.
Dwight Heron, MD, professor of radiation oncology from the University of Pittsburgh Medical Center discusses the emerging role of stereotactic radiosurgery (SRS) as an adjuvant or potentially neoadjuvant treatment for surgical resection. He discusses specifically three indications relating to the above: brain metastases, pancreas cancer and recurrent squamous cell carcinoma of the head and neck.
Wenyin Shi, MD, PhD, Associate Professor of Radiation Oncology at Thomas Jefferson University Hospital in Philadelphia discusses his institution’s evaluation of stereotactic techniques for serial or concomitant treatment of brain metastases. He begins by giving an overview of brain metastases and how radiosurgery (SRS) is becoming the standard of care for their treatment. He then examines Elements Multiple Brain Mets SRS software and compares its results with Gamma Knife plans before evaluating stereotactic techniques, specifically concomitant treatment techniques as compared with serial treatment.
Nzhde Agazaryan, PhD, Professor of Radiation Oncology at the University of California Los Angeles discusses the impact of margins for single isocenter multiple brain metastases radiosurgery treatments. He begins by outlining their commissioning and validation of this methodology as well as patient-specific quality assurance methods. He first outlines the time saved with the software as tracked by his team versus previous planning software, before delving into how margins impact total target volumes and why his institution is now striving to reduce margins.